Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × Perceived Stress Scale × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 559 Specimen Handling 455 Carboplatin 444 Magnetic Resonance Spectroscopy 421 Cisplatin 400 Cyclophosphamide 398 Radiotherapy 316 Gemcitabine 311 Bevacizumab 306 Paclitaxel 297 Biopsy 255 Drug Therapy 250 venetoclax 228 Nivolumab 227 Capecitabine 226 Oxaliplatin 225 fludarabine 222 Injections 211 Docetaxel 203 Fluorouracil 195 Dexamethasone 189 Radiosurgery 165 Rituximab 160 Pemetrexed 158 Standard of Care 146 durvalumab 144 atezolizumab 141 130-nm albumin-bound paclitaxel 135 Leucovorin 133 Etoposide 133

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07326800 2026-04-16

MAEva-MCT

Institut de Cancérologie de Lorraine

Phase NA Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡